Cramer's 'Mad Money' Recap: Bright Spots
Cramer continued his recommendation of Acorda.
Charles River's Win-Win
In his second "Executive Decision" segment, Cramer spoke with James Foster, president and CEO of Charles River Laboratories (CRL) , a company that allows biotech firms to outsource their basic research functions and make critical go, no-go decisions on the new drugs they're developing.
Foster said the biotech industry is at an inflection point because many drugs are coming off patent and companies are scrambling to replace the lost revenue with new drugs. He said for the next two to three years Charles River should be able to continue taking market share as its labs are designed for efficiency and can provide research functions faster and better than the biotechs can by themselves.
Foster said outsourcing to Charles River is a win-win for both firms, as his company is able to provide a very low price point as well as a fast turnaround on the services offered.
When asked whether the company will continue to buy back its own stock, Foster said last year the stock was severely undervalued and the company took advantage of the weakness to buy back shares. Currently, he said, his company is working on two accretive acquisitions, and continues to evaluate the most effective use of cash on hand.
Cramer said investors should take a second look at this very well-run company.
Am I Diversified?
In the "Am I Diversified?" segment, Cramer spoke with callers and responded to tweets sent via Twitter to @JimCramer to see if investors' portfolios have what it takes for today's markets.The first portfolio included: Apple (AAPL) , Mercadolibre (MELI) , Visa (V) , Ford (F) and Lululemon Athletica (LULU) .
Cramer said this portfolio was properly diversified.
Cramer also blessed this portfolio as diversified.
Cramer said Homestreet and Goldman were too similar and he'd sell Homestreet in favor of a biotech stock.
Cramer advised selling Microsoft and adding in Pfizer (PFE) .
No Huddle Offense
In his "No Huddle Offense" segment, Cramer opined on Alcoa's (AA) upbeat outlook for accelerating worldwide economic growth in 2013. How is that possible? he asked.